Chapter 8 The Impact of Astrocytes in the Clearance of Neurotransmitters by Uptake and Inactivation

Advances in Planar Lipid Bilayers and Liposomes

Volumn 9, Issue C, 2009, Pages 211-235

  Perdan, Katja ^a   Lipnik Štangelj, Metoda ^a   Kržan, Mojca ^a  

^a UNIVERSITY OF LJUBLJANA   (Slovenia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77956802100     PISSN: 15544516     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1554-4516(09)09008-5     Document Type: Review

References (119)

1. Virchow R. Über das granulierte Aussehen der Wandungen der Gehirnventrikel. Allg. Z. Psychiatr. 3 (1846) 242-255
2. Mugnaini E., and Walberg F. Ultrastructure of neuroglia. Ergeb. Anat. Entwicklungsgesch. 37 (1964) 194-236
3. Garcia-Marin V., Garcia-Lopez P., and Freire M. Cajal's contributions to glia research. Trends Neurosci. 30 (2007) 479-487
4. Giaume C., and Mc Carthy K.D. Control of gap-junctional communication in astrocytic networks. Trends. Neurosci. 19 (1996) 319-325
5. Verkhratsky A., and Kettenmann H. Calcium signalling in glial cells. Trends. Neurosci. 19 (1996) 346-352
6. Araque A., Parpura V., Sanzgiri R.P., and Haydon P.G. Tripartite synapses: Glia, the unacknowledged partner. Trends. Neurosci. 22 (1999) 208-215
7. Lipnik-Stangelj M. Multiple role of histamine H1-receptor-PKC-MAPK signalling pathway in histamine-stimulated nerve growth factor synthesis and secretion. Biochem. Pharmacol. 72 (2006) 1375-1381
8. Miklic S., Jurič D.M., and Čarman-Kržan M. Differences in the regulation of BDNF and NGF synthesis in cultured neonatal rat astrocytes. Int. J. Dev. Neurosci. 22 (2004) 119-130
9. Moretto G., Xu R.Y., Walker D.G., and Kim S.U. Co-expression of mRNA for neurotrophic factors in human neurons and glial cells in culture. J. Neuropathol. Exp. Neurol. 53 (1994) 78-85
10. Krzan M., Wu V.W., and Schwartz J.P. Serotonin regulation of nerve growth factor synthesis in neonatal and adult astrocytes: Comparison to the beta-adrenergic agonist isoproterenol. J. Neurosci. Res. 64 (2001) 261-267
11. Ma K.C., Nie X.J., Höög A., Olsson Y., and Zhang W.W. Reactive astrocytes in viral infections of the human brain express endothelin-like immunoreactivity. J. Neurol. Sci. 126 (1994) 184-192
12. Wyss-Coray T., Masliah E., Toggas S.M., Rockenstein E.M., Brooker M.J., Lee H.S., and Mucke L. Dysregulation of signal transduction pathways as a potential mechanism of nervous system alterations in HIV-1 gp120 transgenic mice and humans with HIV-1 encephalitis. J. Clin. Invest. 97 (1996) 789-798
13. Faden A.I. Experimental neurobiology of central nervous system trauma. Crit. Rev. Neurobiol. 7 (1993) 175-186
14. Delacourte A. General and dramatic glial reaction in Alzheimer brains. Neurology 40 (1990) 33-37
15. Pike C.J., Cummings B.J., and Cotman C.W. Early association of reactive astrocytes with senile plaques in Alzheimer's disease. Exp. Neurol. 132 (1995) 172-179
16. Rataboul P., Faucon-Biguet N., Vernier P., Vitry F., Boularand S., Privat A., and Mallet J. Identification of a human glial acidic fibrillary protein c DNA: A tool for the molecular analysis of reactive gliosis in the mammalian central nervous system. J. Neurosci. Res. 20 (1988) 165-175
17. Reinhard Jr. J.F., Miller D.B., and O'Callaghan J.P. The neurotoxicant MPTP (1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine) increases glial fibrillary acidic protein and decreases dopamine levels of the mouse striatum: Evidence for glial response to injury. Neurosci. Lett. 95 (1988) 246-251
18. Schneider J.S., and Denaro F.J. Astrocytic responses to the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in cat and mouse brain. J. Neuropathol. Exp. Neurol. 47 (1988) 452-458
19. Ogawa M., Nagatsu I., and Yoshida M. Astroglial cell alteration caused by neurotoxins: Immunohistochemical observations with antibodies to glial fibrillary acidic protein, laminin, and tyrosine hydroxylase. Exp. Neurol. 106 (1989) 187-196
20. Sheng J.G., Shirabe S., Nishiyama N., and Schwartz J.P. Alterations in striatal glial fibrillary acidic protein expression in response to 6-hydroxydopamine-induced denervation. Exp. Brain. Res. 95 (1993) 450-456
21. Magistretti P.J., and Pellerin L. Astrocytes Couple Synaptic Activity to Glucose Utilization in the Brain. News. Physiol. Sci. 14 (1999) 177-182
22. Goldstein G.W. Endothelial cell-astrocyte interactions: A cellular model of the blood brain barrier. Ann. NY. Acad. Sci. 529 (1988) 31-39
23. Raub T.J., Kuentzel S., and Sawada G.A. Permeability of bovine brain microvessel endothelial cells in vitro. Barrier tightening by a factor released from astroglioma cells. Exp. Cell. Res. 199 (1992) 330-340
24. Walz W. Role of astrocytes in the clearance of excess extracellular potassium. Neurochem. Int. 36 (2000) 291-300
25. Gordon G.R., Mulligan S.J., and MacVicar B.A. Astrocyte control of the cerebrovasculature. Glia 55 (2007) 1214-1221
26. Hirase H. A multi-photon window onto neuronal-glial-vascular communication. Trends. Neurosci. 28 (2005) 217-219
27. Cooper J.R., Bloom F.E., and Roth R.H. The biochemical basis of neuropharmacology. 18th Ed. (2003), Oxford University Press, New York
28. +-independent choline transporter in rat astrocytes. J. Neurochem. 94 (2005) 1427-1437
29. Iversen L. Neurotransmitter transporters and their impact on the development of psychopharmacology. Br. J. Pharmacol. 147 (2006) S82-S88
30. Koepsell H., Lips K., and Volk C. Polyspecific organic cation transporters: Structure, function, physiological roles and biopharmaceutical implications. Phram. Res. 24 (2007) 1227-1251
31. Blakely R.D., Ramamoorthy S., Schroeter S., Qian Y., Apparsundaram S., Galli A., and De Felice L.J. Regulated phosphorylation and trafficking of antidepressant-sensitive serotonin transporter proteins. Biol. Psychiatry. 44 (1998) 169-178
32. Blakely R.D., and Bauman A.L. Biogenic amine transporters: Regulation in flux. Curr. Opin. Neurobiol. 10 (2000) 328-336
33. Dingledine R., Borges K., Bowie D., and Traynelis S.F. The glutamate receptor ion channels. Pharmacol. Rev. 51 (1999) 7-61
34. Tanaka K. Role of glutamate transporters in brain development. Nippon Yakurigaku Zasshi 130 (2007) 455-457
35. Chen N.H., Reith M.E., and Quick M.W. Synaptic uptake and beyond: The sodium- and chloride-dependent neurotransmitter transporter family SLC6. Pflugers Arch. 447 (2004) 519-531
36. Grewer C., and Rauen T. Electrogenic glutamate transporters in the CNS: Molecular mechanism, pre-steady-state kinetics, and their impact on synaptic signaling. J. Membr. Biol. 203 (2005) 1-20
37. Slotboom D.J., Konings W.N., and Lolkema J.S. Structural features of the glutamate transporter family. Microbiol. Mol. Biol. Rev. 63 (1999) 293-307
38. Huang Z., and Tajkhorshid E. Dynamics of the extracellular gate and ion-substrate coupling in the glutamate transporter. Biophys. J. 95 (2008) 2292-2300
39. Shigeri Y., Seal R.P., and Shimamoto K. Molecular pharmacology of glutamate transporters, EAATs and VGLUTs. Brain Res. Rev. 45 (2004) 250-265
40. Yernool D., Boudker O., Jin Y., and Gouaux E. Structure of a glutamate transporter homologue from Pyrococcus horikoshii. Nature 431 (2004) 752-753
41. Grunewald M., and Kanner B.I. The accessibility of a novel reentrant loop of the glutamate transporter GLT-1 is restricted by is substrate. J. Biol. Chem. 275 (2000) 9684-9689
42. Seal R.P., and Amara S.G. A reentrant loop domain in the glutamate carrier EAAT1 participates in substrate binding and translocation. Neuron 21 (1998) 1487-1498
43. Borre M.P., Kavanaugh, and Kanner B.I. Dynamic equilibrium between coupled and uncoupled modes of a neuronal glutamate transporter. J. Biol. Chem. 277 (2002) 13501-13507
44. Leighton B.H., Seal R.P., Shimamoto K., and Amara S.G. A hydrophobic domain in glutamate transporters forms an extracellular helix associated with the permeation pathway for substrates. J. Biol. Chem. 277 (2002) 29847-29855
45. Ryan R.M., and Vandenberg R.J. Distinct conformational states mediated the transport and anion channel properties of the glutamate transporter EAAT-1. J. Biol. Chem. 277 (2002) 13494-13500
46. Boudker O., Ryan R.M., Yernool D., Shimamoto K., and Gouaux E. Coupling substrate and ion binding to extracellular gate of a sodium-dependent aspartate transporter. Nature 445 (2007) 387-393
47. Pines G., and Kanner B.I. Counterflow of l-glutamate in plasma membrane vesicles and reconstituted preparations from rat brain. Biochemistry 29 (1990) 11209-11214
48. Kavanaugh M.P., Bendahan A., Zerangue N., Zhang Y., and Kanner B.I. Mutation of an amino acid residue influencing potassium coupling in the glutamate transporter GLT-1 induces obligate exchange. J. Biol. Chem. 272 (1997) 1703-1707
49. +-dependent glutamate uptake. J.Neurosci. 18 (1998) 9620-9628
50. Eliasof S., and Jahr C.E. Retinal glial cell glutamate transporter is coupled to an anionic conductance. Proc. Natl. Acad. Sci. USA 93 (1996) 4153-4158
51. Ryan R.M., and Mindell J.A. The uncoupled chloride conductance of a bacterial glutamate transporter homolog. Nat. Struct. Mol. Biol. 14 (2007) 365-371
52. Ryan R.M., Mitrovic A.D., and Vandenberg R.J. The chloride permeation pathway of a glutamate transporter and its proximity to the glutamate translocation pathway. J. Biol. Chem. 279 (2004) 20742-20751
53. Eskandari S., Kreman M., and Kavanaugh M.P. Pentameric assembly of a neuronal glutamate transporter. Proc. Natl. Acad. Sci. USA 97 (2000) 8641-8646
54. Torres-Salazar D., and Fahlke C. Intersubunit interactions in EAAT4 glutamate transporters. J. Neurosci. 26 (2006) 7513-7522
55. (2+)-dependent exocytosis in cultured astrocytes. Glia 46 (2004) 437-445
56. Zhang Q., Pangrsic T., Kreft M., Krzan M., Li N., Su J.Y., Halassa M., Van Bockstaele E., Zorec R., and Haydon P.G. Fusion-related release of glutamate from astrocytes. J. Biol. Chem. 279 (2004) 12724-12733
57. Montana V., Ni Y., Sunjara V., Hua X., and Parpura V. Vesicular glutamate transporter-dependent glutamate release from astrocytes. J. Neurosci. 24 (2004) 2633-2642
58. McIntire S.L., Reimer R.J., Schuske K., Edwards R.H., and Jorgensen E.M. Identification and characterization of the vesicular GABA transporter. Nature 389 (1997) 870-876
59. Minelli A., Brecha N.C., Karschin C., DeBiasi S., and Conti F. GAT-1, a high-affinity GABA plasma membrane transporter, is localized to neurons and astroglia in the cerebral cortex. J. Neurosci. 15 (1995) 7734-7746
60. Masson J., Sagne C., Hamon M., and Mestikawy S. Neurotransmitter transporters in the central nervous system. Pharmacol. Rev. 51 (1999) 439-464
61. Mabjeesh N.J., Frese M., Rauen T., Jeserich G., and Kanner B.I. Neuronal and glial gamma-aminobutyric acid transporters are distinct proteins. FEBS Lett. 299 (1992) 99-102
62. Guastella J., Nelson N., Nelson H., Czyzyk L., Keynan S., Miedel M.C., Davidson N., Lester H.A., and Kanner B.I. Cloning and expression of a rat brain GABA transporter. Science 249 (1990) 1303-1306
63. Lee T.S., Bjørnsen L.P., Paz C., Kim J.H., Spencer S.S., Spencer D.D., Eid T., and de Lanerolle N.C. GAT1 and GAT3 expression are differently localized in the human epileptogenic hippocampus. Acta Neuropathol 111 (2006) 351-363
64. Schousboe A., and Waagepetersen H.S. Glial modulation of GABAergic and glutamatergic neurotransmission. Curr. Top. Med. Chem. 6 (2006) 929-934
65. Roux M.J., and Suplisson S. Neuronal and glial glycine transporters have different stoichiometries. Neuron 25 (2000) 373-383
66. Gomeza J., Ohno K., Hülsmann S., Armsen W., Eulenburg V., Richter D.W., Laube B., and Betz H. Deletion of the mouse glycine transporter 2 results in a hyperekplexia phenotype and postnatal lethality. Neuron 40 (2003) 797-806
67. Aragon C., and Lopez B. Corcuera, Structure, function and regulation of glycine transporters. Eur. J. Pharmacol. 479 (2003) 249-262
68. Kim K.M., Kingsmore S.F., Han H., Yang-Feng T.L., Godinot N., Seldin M.F., Caron M.G., and Giros B. Cloning of the human glycine transporter type 1: Molecular and pharmacological characterization of novel isoform variants and chromosomal localization of the gene in the human and mouse genomes. Mol. Pharmacol. 45 (1994) 608-617
69. 3H-norepinephrine by tissues. Science 133 (1961) 383-384
70. 3H]-norepinephrine by primary astrocyte cultures and its inhibition by tricyclic antidepressants. J. Neurochem. 40 (1983) 1265-1270
71. Inazu M., Takeda H., and Matsumiya T. Functional expression of the norepinephrine transporter in cultured rat astrocytes. J. Neurochem. 84 (2003) 136-144
72. Kimelberg H.K., and Katz D.M. Regional differences in 5-hydroxytryptamine and catecholamine uptake in primary astrocyte cultures. J. Neurochem. 47 (1986) 1647-1652
73. Eisenhofer G. The role of neuronal and extraneuronal plasma membrane transporters in the inactivation of peripheral catecholamines. Pharmacol. Ther. 91 (2001) 35-62
74. Hansson E. Enzyme activities of monoamine oxidase, catechol-O-methyltransferase and gamma-aminobutyric acid transaminase in primary astroglial cultures and adult rat brain from different brain regions. Neurochem. Res. 9 (1984) 45-57
75. Torres E., and Amara S.G. Glutamate and monoamine transporters: New visions of form and function. Curr. Opin. Neurobiol. 17 (2007) 304-312
76. 3H]5-HT uptake into glial plasmalemmal vesicles. Neurochem. Int. 33 (1998) 11-22
77. Bal N., Figuras G., Vilaró M.T., Suñol C., and Artigas F. Antidepressant drugs inhibit a glial 5-hydroxytryptamine transporter in rat brain. Eur. J. Neurosci. 9 (1997) 1728-1738
78. Inazu M., Takeda H., Ikoshi H., Sugisawa M., Uchida Y., and Matsumiya T. Pharmacological characterization and visualization of the glial serotonin transporter. Neurochem. Int. 39 (2001) 39-49
79. Fitzgerald L.W., Kaplinsky L., and Kimelberg H.K. Serotonin metabolism by monoamine oxidase in rat primary astrocyte cultures. J. Neurochem. 55 (1990) 2008-2014
80. Cragg S.J., and Rice M.E. DAncing past the DAT at a DA synapse. Trends Neurosci. 27 (2004) 270-277
81. Riddle E.L., Fleckenstein A.E., and Hanson G.R. Role of monoamine transporters in mediating psychostimulant effects. AAPS J. 7 (2005) 847-851
82. Giros B., el Mestikawy S., Bertrand L., and Caron M.G. Cloning and functional characterization of a cocaine-sensitive dopamine transporter. FEBS Lett. 295 (1991) 149-154
83. Usdin T.B., Mezey E., Chen C., Brownstein M.J., and Hoffman B.J. Cloning of the cocaine-sensitive bovine dopamine transporter. Proc. Natl. Acad. Sci. USA 88 (1991) 11168-11171
84. Giros B., E4l Mestikawy S., Godinot N., Zheng K., Han H., Yang-Feng T., and Caron M.G. Cloning, pharmacological characterization, and chromosome assignment of the human dopamine transporter. Mol. Pharmacol. 42 (1992) 383-390
85. Inazu M., Takeda H., and Matsumiya T. The role of glial monoamine transporters in the central nervous system. Nihon Shinkei Seishin Yakurigaku Zasshi 2 (2003) 171-178
86. Takeda H., Inazu M., and Matsumiya T. Astroglial dopamine transport is mediated by norepinephrine transporter. Naunyn Schmiedeberg's Arch. Pharmacol. 366 (2002) 620-623
87. Karakaya S., Kipp M., and Beyer C. Oestrogen regulates the expression and function of dopamine transporters in astrocytes of the nigrostriatal system. J. Neuroendocrinol. 9 (2007) 682-690
88. Merickel A., and Edwards H. Transport of histamine by vesicular monoamine transporter-2. Neuropharmacology 34 (1995) 1543-1547
89. Hough L.B., and Domino E.F. Tele-methylhistamine oxidation by type B monoamine oxidase. J. Pharmacol. Exp. Ther. 208 (1979) 422-428
90. Prell G.D., and Green J.P. Measurement of histamine metabolites in brain and cerebrospinal fluid provides insights into histaminergic activity. Agents and Actions 41 (1994) C5-C8
91. 3H]-histamine by glial cells in primary cultures of chicken cerebral hemispheres. Glia 3 (1990) 159-168
92. Huszti Z. Mechanism and function of histamine-sodium cotransport by astroglial cells. Agents Actions 41 (1994) C58-C59
93. Huszti Z. Carrier-mediated high affinity uptake system for histamine in astroglial and cerebral endothelial cells. J. Neurosci. Res. 51 (1998) 551-558
94. Huszti Z. Histamine uptake into non-neuronal brain cells. Inflamm. Res. 52 Suppl. 1 (2003) S03-S06
95. Krzan M., and Schwartz J.P. Histamine transport in neonatal and adult astrocytes. Inflamm. Res. 55 Suppl. 1 (2006) S36-S37
96. Huszti Z., Prast H., Tran M.H., Fischer H., and Philippu A. Glial cells participate in histamine inactivation in vivo. Naunyn Schmiedeberg's Arch. Pharmacol. 357 (1998) 49-53
97. Stuart A.E., Morgan J.R., Mekeel H.E., Kempter E., and Callaway J.C. Selective activity-dependent uptake of histamine into an arthropod photoreceptor. J. Neurosci. 16 (1996) 3178-3188
98. Stuart A.E., Gebhardt K.A., Vogel S.N., and Rodriguez O. Does the neurotransmitter transporter underlie adaptation at a histaminergic photoreceptor synapse?. Vis. Neurosci. 19 (2002) 307-319
99. Sakurai E., Sakurai E., Oreland L., Nishiyama S., Kato M., Watanabe T., and Yanai K. Evidence for the presence of histamine uptake into the synaptosomes of rat brain. Pharmacology 78 (2006) 72-80
100. Gründemann D., Gorboulev V., Gambaryan S., Veyhl M., and Koepsell H. Drug excretion mediated by a new prototype polyspecific transporter. Nature (Lond.) 372 (1994) 549-552
101. Ishiguro N., Saito A., Yokoyama K., Morikawa M., Igarashi T., and Tamai I. Transport of the dopamine D2 agonist pramipexole by rat organic cation transporters OCT1 and OCT2 in kidney. Drug. Metab. Dispos. 33 (2005) 495-499
102. Busch A.E., Karbach U., Miska D., Gorboulev V., Akhoundova A., Volk C., Arndt P., Ulzheimer J.C., Sonders M.S., Baumann C., Waldegger F.L., and Koepsell H. Human neurons express the polyspecific cation transporter hOCT2, which translocates monoamine neurotransmitters, amantadine and memantine. Mol. Pharmacol. 54 (1998) 342-352
103. Russ H., Staust K., Martel F., Gliese M., and Schomig E. The extraneuronal transporter for monoamine transmitters exists in cells derived from human central nervous system glia. Eur. J. Neurosci. 8 (1996) 1256-1264
104. 2) and evidence for the expression of the transporter in the brain. J. Biol. Chem. 273 (1998) 32776-32786
105. Haag C., Berkels R., Grundemann D., Lazar A., Taubert D., and Schömig E. The localisation of the extraneuronal monoamine transporter (EMT) in rat brain. J. Neurochem. 88 (2004) 291-297
106. Amphoux A., Vialou V., Drescher E., Bruss M., Mannoury La Cour C., Rochat C., Millan M.J., Giros B., Bonisch H., and Gautron S. Differential pharmacological in vitro properties of organic cation transporters and regional distribution in rat brain. Neuropharmacol 50 (2006) 941-952
107. Vialou V., Balasse L., Callbert J., Launay J.M., Giros B., and Gautron S. Altered aminergic neurotransmission in the brain of organic cation transporter 3-deficient mice. J. Neurochem. 10 (2008) 1-12
108. Gasser P.J., Lowry C.A., and Orchink M. Corticosterone sensitive monoamine transport in rat dorsomedial hypothalamus: Potential role for organic cation transporter 3 in stress-induced modulation of monoaminergic neurotransmission. J. Neurosci. 26 (2006) 8758-8766
109. Bergles D.E. Neurotransmitter Ttransporters. Encyclopedia of Life Sciences (2001), Nature Publishing Group. and www.els.net
110. Colleoni S., Jensen A.A., Landucci E., Fumagalli E., Conti P., Pinto A., De Amici M., Pellegrini-Giampietro D.E., De Micheli C., Mennini T., and Gobbi M. Neuroprotective effects of the novel glutamate transporter inhibitor (-)-HIP-A which preferentially inhibits reverse transport (glutamate release) compared to glutamate reuptake. J. Pharmacol. Exp. Ther. 135251 (2008) 1-35
111. Lee G., Huang Y., Washington J.M., Briggs N.W., and Zuo Z. Carbamazepine enhances the activity of glutamate transporter type 3 via phosphatidylinositol 3-kinase. Epilepsy Res. 66 (2005) 145-153
112. Borowicz K.K., Zadrozniak Æ.M., Luszczki C.J.J., and Czuczwar C.S.J. Interactions between tiagabine and conventional antiepileptic drugs in the rat model of complex partial seizures. J. Neural. Transm. 115 (2008) 661-667
113. Dalby N.O. GABA-level increasing and anticonvulsant effects of three different GABA uptake inhibitors. Neuropharmacology 39 (2000) 2399-2407
114. 3 injection. Brain Res. 1151 (2007) 55-61
115. Betz H., Gomeza J., Armsen W., Scholze P., and Eulenburg V. Glycine transporters: Essential regulators of synaptic transmission. Mol. Determinants Synaptic Funct. 34 (2006) 55-58
116. Zhou J. Norepinephrine transporter inhibitors and their therapeutic potential. Drugs Future 29 (2004) 1235-1244
117. Jayanthi L.D., and Ramamoorthy S. Regulation of monoamine transporters: Influence of psychostimulants and therapeutic antidepressants. The AAPS J. 7 (2005) E728-E738
118. Brodie M.J. Tiagabine pharmacology in profile. Epilepsia 36 Suppl. 6 (1995) S7-S9
119. Tsai G., Lane H.Y., Yang P., Chong M.Y., and Lange N. Glycine transporter I inhibitor, N-methylglycine (sarcosine), added to antipsychotics for the treatment of schizophrenia. Biol. Psychiatry. 55 (2004) 452-456